Objective: To evaluate the values of 4 tumor markers in serum and ascites and their ascites/serum ratios inthe identification and diagnosis of benign and malignant ascites. Materials and
Methods: A total of 76 patientswere selected as subjects and divided into malignant ascites group (45 cases) and benign ascites group (31cases). Samples of ascites and serum of all hospitalized patients were collected before treatment. The levels ofcarcinoembryonic antigen (CEA), alpha fetoprotein (AFP), cancer antigen 125 (CA125) and carbohydrate antigen19-9 (CA19-9) were detected by chemiluminescence (CLIA) .
Results: CEA, AFP and CA19-9 in both serumand ascites as well as CA125 in ascites were evidently higher in the malignant ascites group than in the benignascites group (P<0.01). Malignant ascites was associated with elevated ascites/serum ratios for AFP and CA125(P<0.01). The areas under receiver operating characteristic (AUROCs) of CEA and CA125 in ascites and theratios of ascites/serum of AFP, CEA, CA125 and CA19-9 were all >0.7, suggesting certain values, while those ofascites CA19-9 and serum CEA were 0.697 and 0.629 respectively, indicating low accuracy in the identificationand diagnosis of benign and malignant ascites. However, the AUROCs of the remaining indexes were <0.5, with novalue for identification and diagnosis. Compared with single index, the sensitivity of combined detection increasedsignificantly (P<0.05), in which the combined detection of CEA, CA19-9 and CA125 in ascites as well as the ratioof ascites/serum of CEA, CA19-9, CA125 and AFP had the highest sensitivity (98.4%) but with relevantly lowspecificity. Both sensitivity and specificity of combined detection should be comprehensively considered so asto choose the most appropriate index.
Conclusions: Compared with single index, combined detection of tumormarkers in serum and ascites can significantly improve the diagnostic sensitivity and specificity.